Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.
Last sync to Obsidian:
20/11/2025, 09:43:23
Cluster of differentiation 30, also TNFSF8, a member of the TNR receptor superfamily. Characteristically associated with anaplastic large cell lymphoma, and Hodgkin Lymphoma.
It is the target of brentuximab.